715
Views
1
CrossRef citations to date
0
Altmetric
Article

Polymorphisms of C-reactive protein and growth arrest-specific gene 6 modulate ischemic stroke susceptibility through gene–gene interactions in Chinese Han population

, , , , &
Pages 937-945 | Received 03 Jan 2020, Accepted 08 Aug 2020, Published online: 16 Sep 2020

References

  • Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation. 2019;139(10):56–528.
  • Thrift A, Thayabaranathan T, Howard G, et al. Global stroke statistics. Int J Stroke. 2017;12(1):13–32.
  • Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015.
  • Della-Morte D, Guadagni F, Palmirotta R, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012;13(5):595–613.
  • Mallolas J, Hurtado O, Castellanos M, et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med. 2006;203(3):711–717.
  • Jerrard-Dunne P, Cloud G, Hassan A, et al. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke. 2003;34(6):1364–1369.
  • Rodriguez-Yanez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol. 2008;21(3):353–357.
  • Shi K, Tian D, Li Z, et al. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–4422.
  • Eldahshan W, Fagan S, Ergul A. Inflammation within the neurovascular unit: focus on microglia for stroke injury and recovery. Pharmacol Res. 2019;147:104349. Epub 2019 Jul 14.
  • Zhao N, Liu X, Wang Y, et al. Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population. J Neuroinflamm. 2012;9:162.
  • Tuttolomondo A, Di Raimondo D, Forte GI, et al. Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine. 2012;58(3):398–405.
  • Arenillas JF, Massot A, Alvarez-Sabin J, et al. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses. Cerebrovasc Dis. 2009;28(1):95–102.
  • Chang SN, Lai LP, Chiang FT, et al. C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study. J Thromb Haemost. 2017;15(8):1541–1546.
  • Shen C, Sun X, Wang H, et al. Association study of CRP gene and ischemic stroke in a Chinese Han population. J Mol Neurosci. 2013;49(3):559–566.
  • Lee CH, Chu NF, Shieh YS, et al. The growth arrest-specific 6 (Gas6) gene polymorphism c.834 + 7G > A is associated with type 2 diabetes. Diabetes Res Clin Pract. 2012;95(2):201–206.
  • Jiang L, Liu CY, Yang QF, et al. Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol. 2009;131(5):738–743.
  • Ben Assayag E, Shenhar-Tsarfaty S, Bova I, et al. Association of the -757T > C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res. 2009;124(4):458–462.
  • Ladenvall C, Jood K, Blomstrand C, et al. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006;37(8):2018–2023.
  • Munoz X, Obach V, Hurtado B, et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost. 2007;98(2):406–412.
  • Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol. 2003;24(2):150–157.
  • Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69(1):138–147.
  • Xu HM, Xu LF, Hou TT, et al. GMDR: versatile software for detecting gene–gene and gene–environment interactions underlying complex traits. Curr Genomics. 2016;17(5):396–402.
  • Moore JH. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn. 2004;4(6):795–803.
  • Stroke–1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989;20(10):1407–1431.
  • Adams H, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
  • Chen C, Nan B, Lin P, et al. C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells. Thromb Res. 2008;122(1):125–133.
  • Han C, Liu J, Liu X, et al. Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis. 2010;212(1):206–212.
  • Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol. 1999;19(10):2348–2354.
  • Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103(9):1194–1197.
  • Huang X, Zhang J, Liu J, et al. C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress. J Cell Biochem. 2012;113(3):857–867.
  • Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82(2):513–520.
  • den Hertog HM, van den Herik EG, Dippel DW, et al. Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis. 2010;29(4):372–375.
  • Kuhlenbaeumer G, Huge A, Berger K, et al. Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke. Cerebrovasc Dis. 2010;30(5):476–482.
  • Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens. 2006;19(6):593–600.
  • Das S, Roy S, Kaul S, et al. CRP gene (1059G > C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a south Indian population. Inflammation. 2014;37(5):1683–1688.
  • Andersson J, Johansson L, Ladenvall P, et al. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovasc Dis. 2009;27(6):544–551.
  • Flex A, Gaetani E, Papaleo P, et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke. 2004;35(10):2270–2275.
  • Furukawa M, Wang X, Ohkawara H, et al. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD. Blood Adv. 2019;3(14):2128–2143.
  • van der Meer JH, van der Poll T, van't Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood. 2014;123(16):2460–2469.
  • Zhou J, Yang A, Wang Y, et al. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation. Cell Commun Signal. 2018;16(1):98.
  • Law LA, Graham DK, Di Paola J, et al. GAS6/TAM pathway signaling in hemostasis and thrombosis. Front Med (Lausanne). 2018;5:137.
  • Hurtado B, Abasolo N, Muñoz X, et al. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. Thromb Haemost. 2010;104(3):592–598.